FLUARIX QUADRIVALENT
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $84.49 | 3 | 3 |
| 2023 | $382.87 | 14 | 14 |
| 2022 | $482.81 | 12 | 12 |
| 2021 | $325.73 | 20 | 20 |
| 2020 | $1,814 | 75 | 71 |
| 2018 | $34.52 | 2 | 2 |
| 2017 | $7,957 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,957 | 9 | 71.8% |
| Food and Beverage | $2,601 | 125 | 23.5% |
| Space rental or facility fees (teaching hospital only) | $523.19 | 1 | 4.7% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase III, observer blind, randomised, controlled, multi centre study to evaluate the immunogenicity and safety of GSK Biologicals quadrivalent influenza vaccine candidate, GSK2282512A FLU Q QIV , compared to Sanofi Pasteur s quadrivalent influenz | GlaxoSmithKline, LLC. | $6,865 | 0 |
| FLU D QIV 004 PRI | GlaxoSmithKline, LLC. | $1,092 | 0 |
Top Doctors Receiving Payments for FLUARIX QUADRIVALENT — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Family Medicine | Frederick, MD | $12.70 | 1 |
| , M.D | Family Medicine | Oxnard, CA | $12.65 | 1 |
| , M.D | Pediatrics | San Antonio, TX | $12.50 | 1 |
| , MD | Pediatrics | San Antonio, TX | $12.50 | 1 |
| , MD | Family Medicine | Powell, TN | $11.89 | 1 |
| , MD | Family Medicine | Powell, TN | $11.89 | 1 |
| , MD | Family Medicine | Powell, TN | $11.89 | 1 |
| , MD | Family Medicine | Knoxville, TN | $11.89 | 1 |
| , MD | Internal Medicine | Chico, CA | $11.20 | 1 |
| , M.D | Pediatrics | Knoxville, TN | $10.93 | 1 |
| , CNP | Adult Health | Gulfport, MS | $9.63 | 1 |
| , M.D | Internal Medicine | Gulfport, MS | $9.63 | 1 |
| , M.D | Internal Medicine | Gulfport, MS | $9.63 | 1 |
| , CPNP | Pediatrics | Charleston, SC | $4.65 | 1 |
| , MD | Allergy & Immunology | Eugene, OR | $4.18 | 1 |
| , M.D | Allergy & Immunology | Eugene, OR | $4.18 | 1 |
| , M.D | Allergy & Immunology | Eugene, OR | $4.18 | 1 |
| , MD | Family Medicine | San Antonio, TX | $3.38 | 1 |
| , MD | Emergency Medicine | Newark, DE | $2.15 | 1 |
Manufacturing Companies
- GlaxoSmithKline, LLC. $11,082
Product Information
- Type Biological
- Total Payments $11,082
- Total Doctors 118
- Transactions 135
About FLUARIX QUADRIVALENT
FLUARIX QUADRIVALENT is a biological associated with $11,082 in payments to 118 healthcare providers, recorded across 135 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2017 to 2024. In 2024, $84.49 was paid across 3 transactions to 3 doctors.
The most common payment nature for FLUARIX QUADRIVALENT is "Unspecified" ($7,957, 71.8% of total).
FLUARIX QUADRIVALENT is associated with 2 research studies, including "A Phase III, observer blind, randomised, controlled, multi centre study to evaluate the immunogenicity and safety of GSK Biologicals quadrivalent influenza vaccine candidate, GSK2282512A FLU Q QIV , compared to Sanofi Pasteur s quadrivalent influenz" ($6,865).